FIELD-APPLICABLE SEROLOGIC DIAGNOSIS AND EXPERIMENTAL CONTROL STRATEGIES

现场适用的血清学诊断和实验控制策略

基本信息

  • 批准号:
    6099804
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-05-01 至 1999-04-30
  • 项目状态:
    已结题

项目摘要

Human Taenia solium cysticercosis is a severely debilitating, yet treatable disease. In the pig, this infection accounts for multimillion dollars of economic loss per year. Preliminary epidemiological surveys with the newly developed immmunoblot assay (EITB) in many Latin American countries, China, and India indicated that this is a significant public health problem with prevalence rates ranging from 8% to 15% in humans and up to 45% in pigs. A recent Centers for Disease Control Survey showed endogenous transmission in families with immigrant domestic workers, resulting in a sero- prevalence of 13% in a single community in Brooklyn alone. Cysticercosis has therefore, acquired a domestic mode. Control of this important public health problem is dependent on the identification and treatment of patient and pigs. We propose to extend and enhance the power, usefulness, and practicality of our unique assay/field operation system toward the detection and control of this important disease. We also propose to test the efficacy of a novel pig/human approach to surveillance and control of cysticercosis. We will: 1. To develop a low cost, robust, and field applicable version of the EITB assay for the detection of human and pig cysticercosis 2, determine the longevity of infection-specific antibodies in treated patients by quantitative isotype assays 3, To test the hypothesis that a single treatment of EITB positive pigs, together with elimination of tape worms in sero-positive human patients, and eduction is a viable and effective approach to the control of human and pig cysticercosis 4, to determine if the serology of cysticercosis-free pigs is a useful and effective sentinel for measuring disease prevalence and control effectiveness of human cysticercosis.
人类带绦虫囊虫病是一种严重使人衰弱的疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT H GILMAN其他文献

UNDERSTANDING ALL-CAUSE MORTALITY AND COPD IN PERU: WHY SPIROMETRY SCREENING MATTERS FOR DIVERSE POPULATIONS
  • DOI:
    10.1016/j.chest.2022.08.1579
  • 发表时间:
    2022-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    ERICA L CROSLEY;SHAKIR HOSSEN;ROBERT H GILMAN;J. JAIME MIRANDA;ANTONIO BERNABÉ-ORTIZ;ROBERT A WISE;WILLIAM CHECKLEY
  • 通讯作者:
    WILLIAM CHECKLEY

ROBERT H GILMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT H GILMAN', 18)}}的其他基金

Infectious Diseases Training program in Bolivia: South-South Training with Peru
玻利维亚传染病培训项目:与秘鲁的南南培训
  • 批准号:
    10838920
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
玻利维亚儿童结核病的诊断创新
  • 批准号:
    10731855
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
使用结核分枝杆菌基因组预测结核病病理、耐药性获得和识别社区传播位点
  • 批准号:
    10392356
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites
使用结核分枝杆菌基因组预测结核病病理、耐药性获得和识别社区传播位点
  • 批准号:
    10598532
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
针对生活在拉丁美洲的艾滋病毒患者的脑弓形体病和恰加斯病的新型纳米诊断
  • 批准号:
    10405524
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
针对生活在拉丁美洲的艾滋病毒患者的脑弓形体病和恰加斯病的新型纳米诊断
  • 批准号:
    10207356
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Oxfendazole as a Broad Spectrum Deworming Medicine in Humans: Phase II Efficacy Study in Geohelminths
奥芬达唑作为人类广谱驱虫药:对土蠕虫的 II 期疗效研究
  • 批准号:
    9143283
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Infectious Diseases Training program in Bolivia: South-South Training with Peru
玻利维亚传染病培训项目:与秘鲁的南南培训
  • 批准号:
    10580728
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Infectious Diseases Training program in Bolivia: South-South Training with Peru
玻利维亚传染病培训项目:与秘鲁的南南培训
  • 批准号:
    10328561
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
秘鲁城郊社区出生队列中诺如病毒和沙波病毒的自然感染
  • 批准号:
    8961698
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Infectious Diseases Training program in Bolivia: South-South Training with Peru
玻利维亚传染病培训项目:与秘鲁的南南培训
  • 批准号:
    10838920
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program
秘鲁范德比尔特 — 通过疫苗接种培训进行预防 (PREVENT) 计划
  • 批准号:
    10674393
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Innovations in Implementing Decentralized HIV Services in Peru
秘鲁实施分散式艾滋病毒服务的创新
  • 批准号:
    10762842
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Doctoral Dissertation Research: The Impact of the Miraflores El Niño Flood on the Chiribaya of Far Southern Peru
博士论文研究:米拉弗洛雷斯厄尔尼诺洪水对秘鲁远南奇里巴亚的影响
  • 批准号:
    2306152
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The cultural legacy of Paralympic media in Peru: Lessons from the Global South
秘鲁残奥会媒体的文化遗产:来自南方国家的经验教训
  • 批准号:
    2788972
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
HIVR4P 2023, the 5th HIV Research for Prevention Conference, Lima, Peru, and virtually, 22-26 October 2023
HIVR4P 2023,第五届艾滋病毒预防研究会议,秘鲁利马,虚拟会议,2023 年 10 月 22-26 日
  • 批准号:
    10617933
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Building Inclusive Recovery through Theatre (BIRTh): people with autism going beyond the COVID-19 pandemic in Peru
通过剧院构建包容性康复 (BIRTh):自闭症患者超越秘鲁的 COVID-19 大流行
  • 批准号:
    AH/X008576/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Open Doors? Cross-border itineraries of Venezuelan migrants in Colombia, Ecuador & Peru
开门?
  • 批准号:
    2881461
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
旨在减少间日疟原虫传播的集中集中药物管理(fMDA),这是秘鲁的一项实用整群随机对照试验
  • 批准号:
    10488139
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Socio-structural barriers and older adults' therapeutic itineraries to access healthcare during the COVID- 19 pandemic in Peru
秘鲁 COVID-19 大流行期间的社会结构障碍和老年人获得医疗保健的治疗行程
  • 批准号:
    2750490
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了